Sansure Biotech Announces Joint Investment with Related Party in Zheyuan Technology

Source: Shell Finance

Beijing News Shell Finance News, March 12Sansure BiotechAnnouncement: The company plans to jointly invest in PHIL RIVERS TECHNOLOGY Co., Ltd with the related party, Hunan Jinfurong Sansure Bio-Equity Investment Fund Partnership (Limited Partnership). The company will invest 40 million yuan of its own funds, and the fund will invest 50 million yuan. After the equity transfer and capital increase transactions, the company will hold 4.02% of PHIL RIVERS TECHNOLOGY's equity, and the fund will hold 5.02% of PHIL RIVERS TECHNOLOGY's equity.